A summary of the Company’s restricted stock unit activity with respect to the nine months ended March 29, 2025 is as follows:


	Number of Shares (in thousands)			Weighted Average Grant Date Fair Value
Nonvested at December 28, 2024		409		$	132.39
Granted		128		$	129.27
Vested		(110	)	$	108.09
Forfeited		(6	)	$	138.19
Nonvested at March 29, 2025		421		$	137.72

Of the 421 thousand nonvested shares outstanding at March 29, 2025, 332 thousand are service-based RSUs and 89 thousand are market-based PRSUs. The fair value of the Company’s service-based RSUs was calculated based on the fair market value of the Company’s common stock at the date of grant. The fair value of the Company’s market-based PRSUs granted during fiscal years 2025 and 2024 was calculated using a Monte Carlo simulation model at the date of the grant, resulting in a weighted average grant-date fair value per share of $140.94 and $251.51, respectively.

The following table presents the detail of share-based compensation expense amounts included in the Company’s Condensed Consolidated Statement of Operations:


	Three Months Ended
	March 29,		March 30,
	2025		2024
	(in thousands)
Cost of revenue	$	1,107	$	1,136
Research and development		1,062		1,287
Sales and marketing		1,339		1,217
General and administrative		3,306		2,846
Total share-based compensation expense	$	6,814	$	6,486

As of March 29, 2025 and December 28, 2024, there was $35.4 million and $29.2 million of total unrecognized compensation cost related to restricted stock units granted under the Company’s stock plans, respectively. That cost is expected to be recognized over a weighted average period of 1.5 and 1.3 years following both March 29, 2025 and December 28, 2024, respectively.